Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tiny worms paving way for better anesthetics

24.10.2005


Ten genes that may make patients more or less susceptible to a common anesthetic agent have been identified by researchers using tiny worms and sophisticated technology that eliminates the activity of individual genes.



“We are anesthetizing 25 million patients a year in the United States alone; we put them to sleep and wake them up and we still don’t know a lot about why it happens,” said Dr. Steffen E. Meiler, vice chair of research for the Medical College of Georgia Department of Anesthesiology and Perioperative Medicine and a study author. “A lot of research has been done but the main mechanisms of how these volatile anesthetics (volatility means the anesthetics move easily from liquid to gaseous form) work have really alluded us.”

Drs. Meiler, Aamir Nazir and their colleagues are taking advantage of advances in genomics and technology to begin to identify those mechanisms with the ultimate goal of better drugs.


“Eventually what we would like to do is design more specific drugs,” says Dr. Meiler of the work being presented during the American Society of Anesthesiologists annual meeting Oct. 22-26 in Atlanta. “The principal question is how can we design anesthetic drugs that have the desired effect of rendering a patient unconscious during surgery without affecting other brain functions that lead to adverse effects,” he says.

Critical pieces have come together to make the studies possible including the relatively recent finding that volatile anesthetics interact with proteins. Now that they know they need to look at proteins, sophisticated RNA interference technology enables researchers to do so by stopping the usual process in which information encoded by a singular gene is transformed into a cellular protein.

Tiny C. elegans, free-living soil nematodes that share 50 percent to 60 percent of their genes with humans and are the first study animals to have their genome decoded and sequenced, have given the scientists a manageable model for knocking out select genes, giving anesthetics and measuring the results.

The researchers started their work with the 637 genes known to be expressed in the nervous system of the C. elegans. They designed a tiny gas chamber to deliver Isofluran to the worms. Not unlike earlier days in anesthesiology – before sophisticated monitoring such as the bispectral index system that measures brainwave activity to determine a patient’s level of consciousness during surgery – the researchers assessed the anesthetic effect from just watching their subjects. They compared the movement of anesthetized worms to controls.

“This is the best genetic model system,” says Dr. Nazir. “The worms we study are about the same age and carry the same genes. If there is a difference between the control and the knock-down mutant, we know that particular gene has something to do with the anesthetic, he says. Using this method, they initially identified 37 candidate genes.

Next, they applied a sophisticated quantification system, developed in conjunction with the California Institute of Technology, that allows 144 precise, objective measures of how far anesthetized worms and the controls travel, including speed, top speed, roaming range, track patterns and other complex behaviors.

That systematic analysis narrowed the field to 10 genes – nine that are hypersensitive and one that is resistant – that are biological modifiers of the anesthetic effects of drugs, Dr. Nazir says.

“These are modifier genes that influence the effect, the degree, the extent of the anesthetic effect,” says Dr. Meiler. “We cannot yet say these are direct targets of volatile anesthetics. That is to be tested in another series of studies.”

Rather, these first steps have shown the researchers their approach works, so they are moving toward a genome screen in these tiny worms that includes genes whose function is unknown.

Drs. Zhong Chen, research associate, and C. Alvin Head, chair of the MCG Department of Anesthesiology, are co-authors on the study.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>